Skip to content

Clinical trials

Phase 3 Chronic Limb-Threatening Ischemia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Chronic Limb-Threatening Ischemia Phase: Phase 3 Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20071
20112
20121
20131
20141
20174
20181
20193
20201
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated5
Recruiting2
Unknown status2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Beijing Northland Biotech. Co., Ltd.2
Ixaka Ltd2
AnGes USA, Inc.1
Boston Scientific Corporation1
Cesca Therapeutics, Inc.1
GWT-TUD GmbH1
Harvest Technologies1
Mahidol University1
Mercator MedSystems, Inc.1
Mt. Sinai Medical Center, Miami1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Chronic Limb-Threatening Ischemia18
Peripheral Arterial Disease6
Peripheral Vascular Diseases5
Diabetes Mellitus3
Arterial Occlusive Diseases2
Cardiovascular Diseases2
Diabetes Mellitus, Type 12
Diabetes Mellitus, Type 22
Ischemia2
Ulcer2

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.